OZEMPIC 0.25MG SOLUTION FOR INJECTION PRE-FILLED 1 PEN
NOVO NORDISK
SKU: 48174
Ozempic 0.25 mg is an injectable medication taken subcutaneously and used in the treatment of type 2 diabetes in adults.
The active ingredient in Ozempic is semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Semaglutide works by stimulating insulin production, suppressing glucagon secretion, and slowing down gastric emptying.
This results in a reduction of blood sugar levels and food staying in the stomach longer, promoting feelings of fullness and reducing appetite to promote weight loss.
Ozempic is usually administered once a week and can be taken with or without food.
Ozempic 0.25 mg Benefits:
• Regulates blood sugar levels in people with type 2 diabetes.
• Promotes weight loss.
• Reduces appetite and increases the feeling of being full.
• Improves blood sugar control.
• Can be taken even if you haven't had any food.
The active ingredient in Ozempic is semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Semaglutide works by stimulating insulin production, suppressing glucagon secretion, and slowing down gastric emptying.
This results in a reduction of blood sugar levels and food staying in the stomach longer, promoting feelings of fullness and reducing appetite to promote weight loss.
Ozempic is usually administered once a week and can be taken with or without food.
Ozempic 0.25 mg Benefits:
• Regulates blood sugar levels in people with type 2 diabetes.
• Promotes weight loss.
• Reduces appetite and increases the feeling of being full.
• Improves blood sugar control.
• Can be taken even if you haven't had any food.
Frequently Bought Together
More From NOVO NORDISK
More From All >10
Featured Items
View all
Recently Viewed
How to apply the cream correctly?
Use this section to explain a set of product features, to link to a series of pages, or to answer common questions.
5-step skin routine you might go for
Use this section to explain a set of product features, to link to a series of pages, or to answer common questions.
